The DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.
ISPMD consensus on the management of premenstrual disorders
Open accessAbstract
The second consensus meeting of the International Society for Premenstrual Disorders (ISPMD) took place in London during March 2011. The primary goal was to evaluate the published evidence and consider the expert opinions of the ISPMD members to reach a consensus on advice for the management of premenstrual disorders. Gynaecologists, psychiatrists, psychologists and pharmacologists each formally presented the evidence within their area of expertise; this was followed by an in-depth discussion leading to consensus recommendations. This article provides a comprehensive review of the outcomes from the meeting. The group discussed and agreed that careful diagnosis based on the recommendations and classification derived from the first ISPMD consensus conference is essential and should underlie the appropriate management strategy. Options for the management of premenstrual disorders fall under two broad categories, (a) those influencing central nervous activity, particularly the modulation of the neurotransmitter serotonin and (b) those that suppress ovulation. Psychotropic medication, such as selective serotonin reuptake inhibitors, probably acts by dampening the influence of sex steroids on the brain. Oral contraceptives, gonadotropin-releasing hormone agonists, danazol and estradiol all most likely function by ovulation suppression. The role of oophorectomy was also considered in this respect. Alternative therapies are also addressed, with, e.g. cognitive behavioural therapy, calcium supplements and Vitex agnus castus warranting further exploration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Pre-intervention, the majority of women reported feeling angry, irritable and oversensitive, which is central to clinical definitions of PMDs [3], and has been reported in previous qualitative PMDs research [7, 76, 77].”
From Evaluation of the relative efficacy of a couple cognitive-behaviour therapy (CBT) for Premenstrual Disorders (PMDs), in comparison to one-to-one CBT and a wait list control: A randomized controlled trial (2017) · cites this paper as [3]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor
Majewska, M. D., Harrison, N. L., Schwartz, R. D., Barker, J. L., & Paul, S. M. (1986) · Science · doi:10.1126/science.2422758 · Cited by 2,225
Greene, R., & Dalton, K. (1953) · BMJ · doi:10.1136/bmj.1.4818.1007 · Cited by 1,819
A double‐blind, placebo‐controlled trial
Pinals, R. S., Kaplan, S. B., Lawson, J. G., & Hepburn, B. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780291202 · Cited by 1,355
GABAA receptors: Subtypes provide diversity of function and pharmacology
Olsen, R. W., & Sieghart, W. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.045 · Cited by 986
Schmidt, P. J., Nieman, L. K., Danaceau, M. A., Adams, L. F., & Rubinow, D. R. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801223380401 · Cited by 765
Self-citationThe prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD)
Halbreich, U. M., Borenstein, J. E., Pearlstein, T., & Kahn, L. S. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(03)00098-2 · Cited by 758
The premenstrual symptoms screening tool (PSST) for clinicians
Steiner, M., Macdougall, M., & Brown, E. (2003) · Archives of Women's Mental Health · doi:10.1007/s00737-003-0018-4 · Cited by 641
Self-citationYonkers, K. A., O’Brien, P. M. S., & Eriksson, E. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60527-9 · Cited by 593
Prevalence, incidence and stability of premenstrual dysphoric disorder in the community
WITTCHEN, H.-U., BECKER, E., LIEB, R., & KRAUSE, P. (2002) · Psychological Medicine · doi:10.1017/s0033291701004925 · Cited by 554
Research works printed but not linked: 1
- Sayegh R, Schiff I, Wurtman J, Spiers P, McDermott J, Wurtman R (1995) The effect of a carbohydrate-rich beverage on mood, appetite, and cognitive function in women with premenstrual syndrome. Obstet Gynecol 86:520–8 · DOI
Cited by
Sorted by citations
Toffoletto, S., Lanzenberger, R. R., Gingnell, M., Poromaa, I. S., & Comasco, E. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.07.025 · Cited by 331
Sundström Poromaa, I., & Gingnell, M. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00380 · Cited by 291
Premenstrual syndrome: A mini review
Ryu, A., & Kim, T. (2015) · Maturitas · doi:10.1016/j.maturitas.2015.08.010 · Cited by 250
Poromaa, I. S., Comasco, E., Sumner, R. L., & Eileen Luders, A. (2020) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2020.100856 · Cited by 217
Cognition, The Menstrual Cycle, and Premenstrual Disorders: A Review
Le, J., Thomas, N., & Gurvich, C. (2020) · Brain Science · doi:10.3390/brainsci10040198 · Cited by 126
Metadata
- Authors
- Consensus Group of the International Society for Premenstrual Disorders, Nevatte, T., O’Brien, P. M. S., Bäckström, T., Brown, C., Dennerstein, L., Endicott, J., Epperson, C. N., Eriksson, E., Freeman, E. W., Halbreich, U., Ismail, K., Panay, N., Pearlstein, T., Rapkin, A., Reid, R., Rubinow, D., Schmidt, P., Steiner, M., Studd, J., Sundström-Poromaa, I., & Yonkers, K.
- Affiliations
- Keele University (GB)
- Royal Stoke University Hospital (GB)
- University of Tennessee Health Science Center (US)
- The University of Melbourne (AU)
- Columbia University (US)
- University of Pennsylvania (US)
- University at Buffalo, State University of New York (US)
- Queen Charlotte's and Chelsea Hospital (GB)
- Brown University (US)
- University of California, Los Angeles (US)
- University of North Carolina at Chapel Hill (US)
- National Institute of Mental Health (US)
- Chelsea and Westminster Hospital (GB)
- Uppsala University (SE)
- Corresponding author
- Nevatte, Tracy
- ORCID
- Venue
- Archives of Women s Mental Health
- Published
- 2013-04-27
- Volume
- 16
- Issue
- 4
- Pages
- 279-291
- ISSN
- 1434-1816 (ISSN-L)
- 1435-1102
- PMC
- PMC3955202
- OpenAlex
- W2024556146
- Cited by
- 211
- References
- 111
- Citations by year
- 2026: 8 · 2025: 13 · 2024: 16 · 2023: 21 · 2022: 16 · 2021: 17 · 2020: 45 · 2019: 16 · 2018: 5 · 2017: 19 · 2016: 10 · 2015: 14 · 2014: 10 · 2013: 1
- FWCI
- 11.90
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Archives of Women s Mental Health (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- UNC Libraries
- Funders
- National Institutes of Health
- National Institute of Mental Health (ZIAMH002865)
- National Institute on Drug Abuse (K24DA030301, R01DA018359)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Menstrual Health and Disorders
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Keywords
- premenstrual disorders, premenstrual dysphoric disorder, premenstrual syndrome, management recommendations, serotonin modulation, selective serotonin reuptake inhibitors, ovulation inhibition, oral contraceptives, GnRH agonist, danazol, estradiol, oophorectomy, sex steroids, cognitive behavioral therapy, calcium supplementation, Vitex agnus-castus, complementary and alternative medicine, diagnosis and classification
- MeSH terms
- Female, Group Processes, Humans, Premenstrual Syndrome, United States
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
